Curex
PrivateLast Round
Series A
Jul 15, 2024
Total Funding Raised
$1M
Company Overview
Curex operates in Healthcare & Life Sciences and is based in Miami, Florida. Its latest recorded funding round was a Series A round in July 2024.
Curex is a telehealth company that provides a platform for at-home allergy testing, online consultations, and personalized sublingual immunotherapy.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, D2C Brands, Subscription Commerce, Patient Engagement
Business Model
B2C
Customer Profile
Subscription SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Curex Comparables
Compare Curex with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Wyndly | 91% | |
| Nectar | 91% | |
| HeyAllergy | 81% |
For institutional investors. Book with your work email.
Curex Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 15, 2024 | ||||
| Seed | Jan 28, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Curex Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Plug and Play Tech Center | Seed |
| Valedor Partners | Seed |
| Red & Blue Ventures | Seed, Series A |
| City Light Capital | Seed |
| Label Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 15, 2024
Completed a Series A funding round.
- Aug 8, 2023
Grew 67% QoQ, from 36 to 60 employees.
For institutional investors. Book with your work email.
Curex Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Curex's valuation, stock price, and market status.
Is Curex a public or private company?
Curex is a private company.
What is the current stock price of Curex?
Curex is a private company, so its shares have no public market price. Caplight tracks Curex's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Curex worth (valuation)?
Valuation information for Curex is not publicly available.
Can I buy Curex stock?
Curex shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Curex's last funding round?
Curex's most recent funding round was Series A on July 15, 2024.
Who are the main investors in Curex?
Key investors in Curex include Label Capital.
Will Curex IPO soon?
No public IPO plans have been announced for Curex.
How can I track Curex secondary market activity?
Caplight tracks bids, offers, and trades in Curex's shares on secondary markets.